0002014361-26-000026.txt : 20260710 0002014361-26-000026.hdr.sgml : 20260710 20260710181811 ACCESSION NUMBER: 0002014361-26-000026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260708 FILED AS OF DATE: 20260710 DATE AS OF CHANGE: 20260710 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hancock Mark CENTRAL INDEX KEY: 0002014361 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-42011 FILM NUMBER: 261169668 MAIL ADDRESS: STREET 1: C/O PACS GROUP, INC. STREET 2: 262 N. UNIVERSITY AVENUE CITY: FARMINGTON STATE: UT ZIP: 84025 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PACS Group, Inc. CENTRAL INDEX KEY: 0002001184 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SKILLED NURSING CARE FACILITIES [8051] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 923144268 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 90 S. 400 W. SUITE 700 CITY: SALT LAKE CITY STATE: UT ZIP: 84101 BUSINESS PHONE: (801) 447-9829 MAIL ADDRESS: STREET 1: 90 S. 400 W. SUITE 700 CITY: SALT LAKE CITY STATE: UT ZIP: 84101 4 1 wk-form4_1783721889.xml FORM 4 X0609 4 2026-07-08 0 0002001184 PACS Group, Inc. PACS 0002014361 Hancock Mark false C/O PACS GROUP, INC. 90 S. 400 W. SUITE 700 SALT LAKE CITY UT 84101 1 0 1 0 1 Common Stock 2026-07-08 4 S 0 20338 45.0689 D 53925478 D Common Stock 2026-07-09 4 S 0 4966 45.0627 D 53920512 D The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2026. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.2861 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $45.00 to $45.255 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ John Mitchell, Attorney-in-Fact 2026-07-10